UniSuper Management Pty Ltd decreased its holdings in McKesson Corporation (NYSE:MCK – Free Report) by 5.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,189 shares of the company’s stock after selling 2,106 shares during the period. UniSuper Management Pty Ltd’s holdings in McKesson were worth $32,146,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. GGM Financials LLC acquired a new stake in shares of McKesson during the third quarter worth about $25,000. State of Wyoming acquired a new stake in shares of McKesson during the second quarter worth about $29,000. Board of the Pension Protection Fund acquired a new stake in shares of McKesson during the fourth quarter worth about $33,000. Kingdom Financial Group LLC. acquired a new stake in shares of McKesson during the fourth quarter worth about $33,000. Finally, Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson during the third quarter worth about $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.
Insider Activity at McKesson
In other McKesson news, CEO Brian S. Tyler sold 4,929 shares of the stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $763.00, for a total value of $3,760,827.00. Following the completion of the transaction, the chief executive officer directly owned 22,845 shares of the company’s stock, valued at approximately $17,430,735. This trade represents a 17.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michele Lau sold 3,550 shares of the stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the completion of the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $2,471,259.23. This trade represents a 52.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 11,822 shares of company stock valued at $8,986,212. 0.08% of the stock is currently owned by corporate insiders.
McKesson Stock Down 0.3%
McKesson (NYSE:MCK – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The company had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. During the same period last year, the company posted $10.12 earnings per share. The firm’s quarterly revenue was up 6.0% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, equities research analysts expect that McKesson Corporation will post 44.28 earnings per share for the current fiscal year.
McKesson Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 8.53%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the stock. UBS Group increased their target price on shares of McKesson from $1,000.00 to $1,050.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Bank of America cut their price target on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating for the company in a report on Monday, April 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $875.00 price target on shares of McKesson in a report on Friday, May 8th. Barclays cut their price target on shares of McKesson from $1,050.00 to $925.00 and set an “overweight” rating for the company in a report on Wednesday. Finally, JPMorgan Chase & Co. cut their price target on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $960.53.
Get Our Latest Analysis on McKesson
McKesson Company Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
See Also
- Five stocks we like better than McKesson
- Build On a Strong Earnings Season With These 3 ETFs
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
